Logo image of NWH-DB-H.CA

NORTHWEST HEALTHCARE PRO (NWH-DB-H.CA) Stock Fundamental Analysis

TSX:NWH-DB-H - Toronto Stock Exchange - CA667495AJ41 - Currency: CAD

99.25  0 (0%)

Fundamental Rating

3

Taking everything into account, NWH-DB-H scores 3 out of 10 in our fundamental rating. NWH-DB-H was compared to 43 industry peers in the Diversified REITs industry. There are concerns on the financial health of NWH-DB-H while its profitability can be described as average. NWH-DB-H does not seem to be growing, but still is valued expensively.


Dividend Valuation Growth Profitability Health

Quickly go to:

4

1. Profitability

1.1 Basic Checks

NWH-DB-H had negative earnings in the past year.
NWH-DB-H had a positive operating cash flow in the past year.
In multiple years NWH-DB-H reported negative net income over the last 5 years.
In the past 5 years NWH-DB-H always reported a positive cash flow from operatings.
NWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFNWH-DB-H.CA Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

1.2 Ratios

NWH-DB-H has a worse Return On Assets (-7.77%) than 69.77% of its industry peers.
Looking at the Return On Equity, with a value of -29.96%, NWH-DB-H is doing worse than 69.77% of the companies in the same industry.
With a Return On Invested Capital value of 4.03%, NWH-DB-H is not doing good in the industry: 65.12% of the companies in the same industry are doing better.
NWH-DB-H had an Average Return On Invested Capital over the past 3 years of 2.72%. This is below the industry average of 5.49%.
The 3 year average ROIC (2.72%) for NWH-DB-H is below the current ROIC(4.03%), indicating increased profibility in the last year.
Industry RankSector Rank
ROA -7.77%
ROE -29.96%
ROIC 4.03%
ROA(3y)0.78%
ROA(5y)1.54%
ROE(3y)1.12%
ROE(5y)4.48%
ROIC(3y)2.72%
ROIC(5y)2.85%
NWH-DB-H.CA Yearly ROA, ROE, ROICNWH-DB-H.CA Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 10 -10 20

1.3 Margins

The Operating Margin of NWH-DB-H (63.56%) is better than 88.37% of its industry peers.
In the last couple of years the Operating Margin of NWH-DB-H has remained more or less at the same level.
With an excellent Gross Margin value of 75.37%, NWH-DB-H belongs to the best of the industry, outperforming 83.72% of the companies in the same industry.
In the last couple of years the Gross Margin of NWH-DB-H has remained more or less at the same level.
Industry RankSector Rank
OM 63.56%
PM (TTM) N/A
GM 75.37%
OM growth 3Y-1.89%
OM growth 5Y-1.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.2%
NWH-DB-H.CA Yearly Profit, Operating, Gross MarginsNWH-DB-H.CA Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 50 -50 100

More info and screens

3

2. Health

2.1 Basic Checks

NWH-DB-H has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
Compared to 1 year ago, NWH-DB-H has more shares outstanding
NWH-DB-H has more shares outstanding than it did 5 years ago.
Compared to 1 year ago, NWH-DB-H has a worse debt to assets ratio.
NWH-DB-H.CA Yearly Shares OutstandingNWH-DB-H.CA Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 50M 100M 150M 200M
NWH-DB-H.CA Yearly Total Debt VS Total AssetsNWH-DB-H.CA Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2B 4B 6B 8B

2.2 Solvency

NWH-DB-H has an Altman-Z score of 3.25. This indicates that NWH-DB-H is financially healthy and has little risk of bankruptcy at the moment.
The Altman-Z score of NWH-DB-H (3.25) is better than 86.05% of its industry peers.
The Debt to FCF ratio of NWH-DB-H is 35.83, which is on the high side as it means it would take NWH-DB-H, 35.83 years of fcf income to pay off all of its debts.
NWH-DB-H has a Debt to FCF ratio of 35.83. This is amonst the worse of the industry: NWH-DB-H underperforms 81.40% of its industry peers.
A Debt/Equity ratio of 1.75 is on the high side and indicates that NWH-DB-H has dependencies on debt financing.
NWH-DB-H's Debt to Equity ratio of 1.75 is on the low side compared to the rest of the industry. NWH-DB-H is outperformed by 83.72% of its industry peers.
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 35.83
Altman-Z 3.25
ROIC/WACC0.55
WACC7.35%
NWH-DB-H.CA Yearly LT Debt VS Equity VS FCFNWH-DB-H.CA Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 1B 2B 3B

2.3 Liquidity

NWH-DB-H has a Current Ratio of 0.27. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
NWH-DB-H has a better Current ratio (0.27) than 60.47% of its industry peers.
NWH-DB-H has a Quick Ratio of 0.27. This is a bad value and indicates that NWH-DB-H is not financially healthy enough and could expect problems in meeting its short term obligations.
With a decent Quick ratio value of 0.27, NWH-DB-H is doing good in the industry, outperforming 60.47% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.27
Quick Ratio 0.27
NWH-DB-H.CA Yearly Current Assets VS Current LiabilitesNWH-DB-H.CA Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 500M 1B 1.5B

More info and screens

2

3. Growth

3.1 Past

NWH-DB-H shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -57.42%.
NWH-DB-H shows a strong growth in Revenue. In the last year, the Revenue has grown by 22.83%.
Measured over the past years, NWH-DB-H shows a small growth in Revenue. The Revenue has been growing by 7.76% on average per year.
EPS 1Y (TTM)-57.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.49%
Revenue 1Y (TTM)22.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.76%
Sales Q2Q%-12.43%

3.2 Future

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
EPS Next Y6.98%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year3.1%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

No EPS estimates are available, so we could not analyze the future EPS growth and evolution.
No Revenue estimates are available, so we could not analyze the future revenue growth and evolution.
NWH-DB-H.CA Yearly Revenue VS EstimatesNWH-DB-H.CA Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 100M 200M 300M 400M 500M
NWH-DB-H.CA Yearly EPS VS EstimatesNWH-DB-H.CA Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 0.5 1 1.5

More info and screens

1

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for NWH-DB-H. In the last year negative earnings were reported.
The Price/Forward Earnings ratio is 106.81, which means the current valuation is very expensive for NWH-DB-H.
NWH-DB-H's Price/Forward Earnings is on the same level as the industry average.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.65, NWH-DB-H is valued quite expensively.
Industry RankSector Rank
PE N/A
Fwd PE 106.81
NWH-DB-H.CA Price Earnings VS Forward Price EarningsNWH-DB-H.CA Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 200 400 600

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as NWH-DB-H.
88.37% of the companies in the same industry are cheaper than NWH-DB-H, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 284.44
EV/EBITDA 69.81
NWH-DB-H.CA Per share dataNWH-DB-H.CA EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 2 4 6

4.3 Compensation for Growth

The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2YN/A
EPS Next 3YN/A

More info and screens

4

5. Dividend

5.1 Amount

With a Yearly Dividend Yield of 10.04%, NWH-DB-H is a good candidate for dividend investing.
NWH-DB-H's Dividend Yield is rather good when compared to the industry average which is at 8.03. NWH-DB-H pays more dividend than 90.70% of the companies in the same industry.
NWH-DB-H's Dividend Yield is rather good when compared to the S&P500 average which is at 2.27.
Industry RankSector Rank
Dividend Yield 10.04%

5.2 History

The dividend of NWH-DB-H decreases each year by -3.23%.
NWH-DB-H is new to the dividend game and has less than 3 years of track record.
Dividend Growth(5Y)-3.23%
Div Incr Years0
Div Non Decr Years0

5.3 Sustainability

The earnings of NWH-DB-H are negative and hence is the payout ratio. NWH-DB-H will probably not be able to sustain this dividend level.
DP-16.42%
EPS Next 2YN/A
EPS Next 3YN/A
NWH-DB-H.CA Yearly Income VS Free CF VS DividendNWH-DB-H.CA Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 0 200M -200M 400M

More info and screens

NORTHWEST HEALTHCARE PRO

TSX:NWH-DB-H (2/21/2025, 7:00:00 PM)

99.25

0 (0%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)11-14 2024-11-14
Earnings (Next)03-05 2025-03-05/amc
Inst Owners22.5%
Inst Owner ChangeN/A
Ins Owners0.2%
Ins Owner ChangeN/A
Market Cap24.59B
Analysts70
Price Target117.99 (18.88%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 10.04%
Yearly Dividend0.61
Dividend Growth(5Y)-3.23%
DP-16.42%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)-2.05%
PT rev (3m)5.05%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 106.81
P/S 39.84
P/FCF 284.44
P/OCF 281.57
P/B 14.95
P/tB 15.83
EV/EBITDA 69.81
EPS(TTM)-2
EYN/A
EPS(NY)0.93
Fwd EY0.94%
FCF(TTM)0.35
FCFY0.35%
OCF(TTM)0.35
OCFY0.36%
SpS2.49
BVpS6.64
TBVpS6.27
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA -7.77%
ROE -29.96%
ROCE 6.57%
ROIC 4.03%
ROICexc 4.07%
ROICexgc 4.15%
OM 63.56%
PM (TTM) N/A
GM 75.37%
FCFM 14.01%
ROA(3y)0.78%
ROA(5y)1.54%
ROE(3y)1.12%
ROE(5y)4.48%
ROIC(3y)2.72%
ROIC(5y)2.85%
ROICexc(3y)2.77%
ROICexc(5y)2.96%
ROICexgc(3y)2.82%
ROICexgc(5y)3.03%
ROCE(3y)4.43%
ROCE(5y)4.64%
ROICexcg growth 3Y-5.44%
ROICexcg growth 5Y-2.28%
ROICexc growth 3Y-5.29%
ROICexc growth 5Y-1.28%
OM growth 3Y-1.89%
OM growth 5Y-1.39%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-0.15%
GM growth 5Y0.2%
F-Score5
Asset Turnover0.1
Health
Industry RankSector Rank
Debt/Equity 1.75
Debt/FCF 35.83
Debt/EBITDA 7.28
Cap/Depr 25.64%
Cap/Sales 0.14%
Interest Coverage 1.88
Cash Conversion 22.07%
Profit Quality N/A
Current Ratio 0.27
Quick Ratio 0.27
Altman-Z 3.25
F-Score5
WACC7.35%
ROIC/WACC0.55
Cap/Depr(3y)28.77%
Cap/Depr(5y)23.76%
Cap/Sales(3y)0.1%
Cap/Sales(5y)0.09%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-57.42%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-69.49%
EPS Next Y6.98%
EPS Next 2YN/A
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)22.83%
Revenue growth 3Y10.77%
Revenue growth 5Y7.76%
Sales Q2Q%-12.43%
Revenue Next Year3.1%
Revenue Next 2YN/A
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y21.15%
EBIT growth 3Y8.67%
EBIT growth 5Y6.26%
EBIT Next Year10.78%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-56.25%
FCF growth 3Y-17.82%
FCF growth 5Y2.41%
OCF growth 1Y-55.96%
OCF growth 3Y-17.83%
OCF growth 5Y2.35%